Search
for

    Research

    5 / 1000+ results

    Community Join

    5 / 309 results

      community Quote from Pelage (PP-405) Spokesperson...

       122 upvotes 10 months ago
      Pelage is developing a topical hair follicle stem cell therapy, PP405, for non-scarring alopecias like androgenetic alopecia, with Phase III trials planned and a potential market launch by 2027. The treatment may not require continuous use after initial regrowth.

      community Anagen (@anagenxyz) claiming they've cracked scalp-only DHT blocking - thoughts?

       15 upvotes 3 days ago
      A company is developing a topical dutasteride that targets hair follicles without significantly affecting systemic DHT levels, with trials underway to measure its effectiveness. Users discuss the potential benefits and skepticism around the formulation compared to existing treatments.

      community What’s your views on clascoterone 5% topical solution by cosmo

       23 upvotes 9 months ago
      Clascoterone 5% topical solution shows promise for treating male-pattern hair loss by blocking DHT at the follicle without systemic absorption, potentially offering fewer side effects than oral treatments like finasteride. While results are promising, long-term safety and effectiveness need further study, and it may serve as a starting point for developing more effective treatments.

      community PP405 Never Worked: the follicles were already activated at baseline

       17 upvotes 2 months ago
      PP405 was ineffective for hair growth as some follicles were already active before treatment, raising doubts about its efficacy. Users discussed other hair loss treatments like Minoxidil, finasteride, and RU58841, expressing skepticism and hope for future solutions.

    Learn

    5 / 801 results